MT-200605

N/A

Report date: 2025/10/15 09:21:22
NME

Base Information

Drug NameMT-200605
Drug Alias NameMT-200605MT200605
ClassificationSmall molecules
Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 2 stimulantsFree radicals scavengers
TargetsNeurotrophic tyrosine kinase receptor type 2Free radicals
Therapy Area/IndicationsIschemic StrokeOverweightObesity +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShaanxi Micot Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShaanxi Micot Pharmaceutical Technology Co LtdShanghai Xizaili Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokeOverweightObesity +[5] 
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A